InterCure Reports Record Preliminary Q2 2022 Revenue – More Than Double YoY

InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) released preliminary financial results for the second quarter of 2022, revealing record revenue estimated to be CA$36 million ($27,86 million), more than double the revenues of the second quarter of 2021 and representing sequential growth of over 9%.

Preliminary Q2 2022 Financial Highlights and Milestones

  • Tenth consecutive quarter of high growth representing an annualized run rate of CA$143 million.

  • Company expects continued increases in revenues during the third quarter of 2022.

  • Sustained market share growth due to solid demand for Canndoc's branded products and …

Full story available on Benzinga.com

InterCure Reports Record Preliminary Q2 2022 Revenue – More Than Double YoY on Benzinga